Clinical trial of NPI-0052 in advanced malignancies including lymphoma and leukemia (advanced malignancies arm)

Amanda Townsend,Michael Millward,Timothy Jay Price,Paul N. Mainwaring,Andrew Spencer,Angie M. Longenecker,Michael A. Palladino,G. K. Lloyd,Matthew A. Spear,Peeter Padrik

Clinical trial of NPI-0052 in advanced malignancies including lymphoma and leukemia (advanced malignancies arm)

2009

Amanda Townsend
Michael Millward
Timothy Jay Price
Paul N. Mainwaring
Andrew Spencer
Angie M. Longenecker
Michael A. Palladino
G. K. Lloyd
Matthew A. Spear
Peeter Padrik

3582 Background: The novel structure (non-peptide based) of NPI-0052 (NPI) appears to lead to unique proteasome inhibition (PI), toxicology and signal transduction profiles. Preclinical research su...

Keywords:

Lymphoma
Clinical trial
Leukemia
Oncology
Cancer research
Medicine
Internal medicine
Proteasome Inhibition
Signal transduction
preclinical research

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations